The Diabetes Advocacy Alliance™ (DAA) is a coalition of 21 members, representing patient, professional and trade associations, other nonprofit organizations, and corporations, all united in the desire to change the way diabetes is viewed and treated in America. The DAA was formed and began activities in January 2010. Three members of the DAA serve as co-chairs: American Diabetes Association; Pediatric Endocrine Society; and Novo Nordisk Inc.
The members of the DAA work to inform and educate legislators and other policymakers about:
The vision of the DAA is: To influence change in the US health care system to improve diabetes prevention, detection and care and to speed the development of pathways to cures for diabetes.
The mission of the DAA is: To unite and align key diabetes stakeholders and the larger diabetes community around key diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.
You can also contact Amy Wotring at: email@example.com.